The Biotech Investor's Bible

by George Wolff

Overview

A one-stop source for investing in biotech-with detailed coverage of the science, the business, the players, and the strategies for one of today's most promising (and volatile) industries

To invest in biotech is to invest in the future, and as such, investors need to learn the nuances of the science they're putting their money on. The core asset of biotech companies is knowledge, and sound investment decisions are impossible without an understanding of this complex science. That's where The Biotech Investor's Bible fits in. This much-needed, one-of-a-kind resource simplifies the complex science surrounding the business of biotech and clarifies subtle distinctions within the context of their financial repercussions. The book explains the basics of genetics, patents, and therapies; and teaches investors how to value biotech companies and their state-of-the art products and technology. The Biotech Investor's Bible offers an informative summary of the relatively short history of the industry and provides a comprehensive review of various industry sectors.

Product Details

ISBN-13:	9780471412793
Publisher:	Wiley
Publication date:	06/13/2001
Pages:	336
Product dimensions:	6.32(w) x 9.35(h) x 1.11(d)

About the Author

GEORGE WOLFF is an award-winning journalist and, currently, a private business consultant to several firms in the investment industry. He has assessed and reported on more than 200 biotechnology companies for his clientele, issuing a number of valuable white papers charting the emergence of biotechnology. Previously, as a journalist, Wolff worked internationally covering the onset of the AIDS epidemic, the emergence of recombinant DNA technology, and the extraordinary stock market events of the previous twenty years. Wolff can be contacted through his web site, BioWolff.com.

Table of Contents

PART I.

Introduction.

On the Threshold.

Assessing the Biotech Market.

The Keys to Biotech Investing.

Going Over Biotech Books.

The Four Tiers of Biotech Companies.

Biotechnology and Portfolio Planning.

Decision Making.

The Sector in Perspective.

The Biotech Investor's Checklist.

PART II.

The Science Behind the Industry.

The Language of Genes.

The Realms of Biotechnology (or Who's Doing What).

The Pick and Shovels of Biotechnology.

The New Biotech Therapies.

Special Sectors.

Appendix A: A Breakdown of 185 Major Biotech Companies.

Appendix B: Resources.

Appendix C: A Glossary of Terms.

Notes.

Index.

Editorial Reviews

An investment consultant, formerly a journalist who reported on the emergence of recombinant DNA technology, discusses the maturing biotech sector from new investment strategy and scientific/ technological perspectives. Appendices include a breakdown of 185 major biotech companies by market cap and tier, resources, and a glossary of biotech terms. Annotation c. Book News, Inc., Portland, OR (booknews.com)

Booknews